|
|
|
|
Statement of Financial Position |
2024 |
2023 |
|
Note |
£ |
£ |
Tangible assets |
5 |
|
|
Investments |
6 |
|
|
Biological assets |
7 |
|
|
------------ |
------------ |
||
|
|
||
Stocks |
|
|
|
Debtors |
8 |
|
|
Cash at bank and in hand |
|
|
|
------------ |
------------ |
||
|
|
||
Creditors: amounts falling due within one year |
9 |
|
|
------------ |
------------ |
||
Net current assets |
|
|
|
------------ |
------------ |
||
Total assets less current liabilities |
|
|
|
Creditors: amounts falling due after more than one year |
10 |
|
|
Provisions |
|
|
------------ |
------------ |
|
Net assets |
|
|
------------ |
------------ |
|
Called up share capital |
|
|
Revaluation reserve |
|
|
Profit and loss account |
|
|
------------ |
------------ |
|
Shareholders funds |
|
|
------------ |
------------ |
|
|
Statement of Financial Position (continued) |
|
Director |
|
Notes to the Financial Statements |
Buildings |
- |
|
|
Plant and machinery |
- |
|
|
Turbine and solar |
- |
|
|
Motor vehicles |
- |
|
|
Freehold property |
Plant and machinery |
Turbine and solar |
Motor vehicles |
Total |
|
£ |
£ |
£ |
£ |
£ |
|
Cost |
|||||
At 1 March 2023 and 29 February 2024 |
|
|
|
|
|
------------ |
--------- |
------------ |
-------- |
------------ |
|
Depreciation |
|||||
At 1 March 2023 |
|
|
|
|
|
Charge for the year |
|
|
|
|
|
------------ |
--------- |
------------ |
-------- |
------------ |
|
At 29 February 2024 |
|
|
|
|
|
------------ |
--------- |
------------ |
-------- |
------------ |
|
Carrying amount |
|||||
At 29 February 2024 |
|
|
|
|
|
------------ |
--------- |
------------ |
-------- |
------------ |
|
At 28 February 2023 |
|
|
|
|
|
------------ |
--------- |
------------ |
-------- |
------------ |
|
Other investments other than loans |
|
£ |
|
Cost |
|
At 1 March 2023 and 29 February 2024 |
|
---- |
|
Impairment |
|
At 1 March 2023 and 29 February 2024 |
– |
---- |
|
Carrying amount |
|
At 29 February 2024 |
|
---- |
|
At 28 February 2023 |
|
---- |
|
|
|
|
Total |
|
£ |
£ |
£ |
£ |
|
Valuation |
||||
At 1 March 2023 |
|
126,300
|
|
|
Loss on changes in fair value less costs to sell |
– |
– |
– |
– |
Purchases |
– |
|
– |
|
Sales |
– |
(
|
– |
(
|
Harvest |
– |
– |
(
|
(
|
Other changes |
18,900 |
170,192
|
51,782
|
240,874
|
--------- |
--------- |
-------- |
--------- |
|
At 29 February 2024 |
|
121,500
|
|
|
--------- |
--------- |
-------- |
--------- |
|
2024 |
2023 |
|
£ |
£ |
|
Trade debtors |
|
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
|
Other debtors |
|
|
------------ |
------------ |
|
|
|
|
------------ |
------------ |
|
2024 |
2023 |
|
£ |
£ |
|
Bank loans and overdrafts |
|
|
Trade creditors |
|
|
Accruals and deferred income |
|
|
Corporation tax |
|
|
Social security and other taxes |
|
|
Obligations under finance leases and hire purchase contracts |
|
|
--------- |
--------- |
|
|
|
|
--------- |
--------- |
|
2024 |
2023 |
|
£ |
£ |
|
Bank loans and overdrafts |
|
|
Obligations under finance leases and hire purchase contracts |
– |
|
------------ |
------------ |
|
|
|
|
------------ |
------------ |
|